Share Price and Basic Stock Data
Last Updated: January 8, 2026, 9:11 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CNI Research Ltd operates within the Finance & Investments sector, with its stock currently priced at ₹9.27 and a market capitalization of ₹106 Cr. The company reported sales of ₹9.59 Cr for the fiscal year ending March 2023, which represents a slight increase from ₹7.86 Cr in the previous fiscal year. However, the trailing twelve months (TTM) sales significantly declined to ₹0.38 Cr, indicating a troubling trend. Quarterly sales varied considerably, peaking at ₹3.40 Cr in September 2022 but experiencing a notable drop to ₹0.93 Cr in March 2023. The latest quarter ending September 2023 recorded sales of ₹2.56 Cr. This volatility raises concerns about the company’s revenue stability and market positioning. Despite the fluctuations, the recorded expenses for FY 2023 stood at ₹10.45 Cr, suggesting that the company has faced increasing operational pressures, which may have contributed to the decline in profitability.
Profitability and Efficiency Metrics
CNI Research Ltd has faced significant challenges in profitability, evidenced by a reported net profit of ₹-0.86 Cr for FY 2023, down from ₹1.70 Cr in FY 2022. The operating profit margin (OPM) was negative at -8.97%, contrasting sharply with the previous year’s OPM of 21.88%. The company also recorded a disappointing OPM of -250.00% in the latest quarterly report for September 2025, which is alarming and indicates a severe decline in operational efficiency. The return on equity (ROE) stood at 25.3%, which is commendable relative to industry averages, but the return on capital employed (ROCE) at -7.85% for FY 2023 reflects inefficiencies in generating returns from capital investments. Additionally, the cash conversion cycle remains at zero days, indicating efficient cash management but raising questions about revenue generation capability. Overall, the firm’s profitability metrics reveal a troubling picture, characterized by negative profit figures and declining margins.
Balance Sheet Strength and Financial Ratios
CNI Research Ltd maintains a strong balance sheet, with reported reserves of ₹4.76 Cr and no borrowings as of the latest reporting period, showcasing financial prudence. The company has a price-to-book value (P/BV) ratio of 3.04x, indicating that the market values the company’s equity at a premium compared to its book value, which stood at ₹1.30 per share as of March 2024. The current ratio is exceptionally high at 108.57, suggesting a robust liquidity position that exceeds typical thresholds for the finance sector. However, the enterprise value of ₹42.86 Cr relative to net operating revenue of ₹4.34x signals that investors may be paying a premium for the company’s current revenue performance. The total liabilities for FY 2025 are reported at ₹16.30 Cr, reflecting a stable financial footing. Nonetheless, the declining net profit margins, which stood at 7.98% in FY 2024, point to potential challenges in maintaining profitability amidst rising operational costs.
Shareholding Pattern and Investor Confidence
The shareholding pattern of CNI Research Ltd reveals a stable yet cautious investor sentiment. Promoters hold 37.11% of the company, maintaining their stake consistently since December 2022. The public holds 62.81%, indicating a broad base of retail investors, with the total number of shareholders increasing to 18,903. Foreign institutional investors (FIIs) have gradually entered, holding 0.09% as of September 2025, which could signal a growing interest from external investors. However, the lack of significant institutional investment may indicate a perceived risk or lack of confidence in the company’s growth prospects. The increase in shareholders from 13,103 in December 2022 to 18,903 in September 2025 suggests that despite recent financial struggles, there is still interest in the stock, potentially due to the company’s long-standing presence in the finance sector.
Outlook, Risks, and Final Insight
The outlook for CNI Research Ltd hinges on its ability to stabilize revenues and improve profitability in a challenging market environment. The company’s significant fluctuations in sales and profitability metrics present risks that could deter potential investors. The high operating expenses relative to sales highlight the need for operational efficiency improvements. Furthermore, external factors such as market competition and economic conditions could further impact performance. However, the absence of debt and a robust liquidity position could provide some buffer against short-term financial pressures. To regain investor confidence, the company must focus on strategic initiatives to enhance operational efficiency and revenue generation. Overall, while the firm has strengths in its balance sheet and equity structure, the persistent losses and declining margins pose significant risks that must be addressed for long-term viability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.7 Cr. | 39.8 | 61.0/36.4 | 46.6 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,433 Cr. | 307 | 484/280 | 15.6 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 29.5 Cr. | 0.42 | 1.62/0.38 | 4.09 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.04 Cr. | 10.2 | 11.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 20.8 Cr. | 40.5 | 69.9/38.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,299.82 Cr | 1,354.49 | 76.84 | 3,844.57 | 0.35% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.40 | 3.04 | 0.93 | 2.43 | 2.56 | 1.86 | 2.78 | 4.00 | 0.33 | 0.05 | 0.03 | 0.28 | 0.02 |
| Expenses | 3.29 | 2.95 | 0.97 | 2.47 | 2.50 | 1.78 | 2.82 | 3.96 | 3.32 | 0.95 | 0.14 | 0.25 | 0.07 |
| Operating Profit | 0.11 | 0.09 | -0.04 | -0.04 | 0.06 | 0.08 | -0.04 | 0.04 | -2.99 | -0.90 | -0.11 | 0.03 | -0.05 |
| OPM % | 3.24% | 2.96% | -4.30% | -1.65% | 2.34% | 4.30% | -1.44% | 1.00% | -906.06% | -1,800.00% | -366.67% | 10.71% | -250.00% |
| Other Income | 0.12 | 0.47 | -1.82 | 0.66 | 0.09 | -0.28 | 0.32 | 0.18 | -0.17 | 0.00 | 0.01 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.23 | 0.56 | -1.86 | 0.62 | 0.15 | -0.20 | 0.28 | 0.22 | -3.16 | -0.90 | -0.10 | 0.03 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.23 | 0.56 | -1.86 | 0.62 | 0.15 | -0.20 | 0.27 | 0.22 | -3.16 | -0.90 | -0.10 | 0.03 | -0.05 |
| EPS in Rs | 0.02 | 0.05 | -0.16 | 0.05 | 0.01 | -0.02 | 0.02 | 0.02 | -0.28 | -0.08 | -0.01 | 0.00 | -0.00 |
Last Updated: December 27, 2025, 12:36 pm
Below is a detailed analysis of the quarterly data for CNI Research Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.28 Cr. (Jun 2025) to 0.02 Cr., marking a decrease of 0.26 Cr..
- For Expenses, as of Sep 2025, the value is 0.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.25 Cr. (Jun 2025) to 0.07 Cr., marking a decrease of 0.18 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Jun 2025) to -0.05 Cr., marking a decrease of 0.08 Cr..
- For OPM %, as of Sep 2025, the value is -250.00%. The value appears to be declining and may need further review. It has decreased from 10.71% (Jun 2025) to -250.00%, marking a decrease of 260.71%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Jun 2025) to -0.05 Cr., marking a decrease of 0.08 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Jun 2025) to -0.05 Cr., marking a decrease of 0.08 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.00. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:56 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.89 | 22.66 | 48.53 | 1.80 | 4.40 | 4.03 | 2.33 | -2.31 | 7.86 | 9.59 | 10.58 | 4.44 | 0.38 |
| Expenses | 3.19 | 23.93 | 48.25 | 2.18 | 4.51 | 4.53 | 2.58 | 1.30 | 6.14 | 10.45 | 9.73 | 8.38 | 1.41 |
| Operating Profit | -0.30 | -1.27 | 0.28 | -0.38 | -0.11 | -0.50 | -0.25 | -3.61 | 1.72 | -0.86 | 0.85 | -3.94 | -1.03 |
| OPM % | -10.38% | -5.60% | 0.58% | -21.11% | -2.50% | -12.41% | -10.73% | -10.17% | 21.88% | -8.97% | 8.03% | -88.74% | -271.05% |
| Other Income | 0.34 | 2.54 | -0.71 | 0.52 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.01 | 1.27 | -0.43 | 0.14 | 0.11 | -0.50 | -0.25 | -3.61 | 1.72 | -0.86 | 0.85 | -3.94 | -1.02 |
| Tax % | -1,600.00% | 20.47% | 0.00% | 14.29% | 18.18% | 0.00% | 0.00% | 0.00% | 1.16% | 0.00% | 1.18% | 0.00% | |
| Net Profit | 0.17 | 1.01 | -0.43 | 0.11 | 0.09 | -0.50 | -0.25 | -3.61 | 1.70 | -0.86 | 0.84 | -3.94 | -1.02 |
| EPS in Rs | 0.03 | 0.09 | -0.04 | 0.01 | 0.01 | -0.04 | -0.02 | -0.31 | 0.15 | -0.07 | 0.07 | -0.34 | -0.09 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 494.12% | -142.57% | 125.58% | -18.18% | -655.56% | 50.00% | -1344.00% | 147.09% | -150.59% | 197.67% | -569.05% |
| Change in YoY Net Profit Growth (%) | 0.00% | -636.69% | 268.16% | -143.76% | -637.37% | 705.56% | -1394.00% | 1491.09% | -297.68% | 348.26% | -766.72% |
CNI Research Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | 14% |
| 3 Years: | -17% |
| TTM: | -94% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1039% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 50% |
| 3 Years: | 49% |
| 1 Year: | -1% |
| Return on Equity | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -11% |
| 3 Years: | -10% |
| Last Year: | -25% |
Last Updated: September 5, 2025, 3:01 pm
Balance Sheet
Last Updated: January 7, 2026, 5:14 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.48 | 10.94 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 |
| Reserves | 5.61 | 11.35 | 11.19 | 6.48 | 4.72 | 0.24 | -5.93 | -3.67 | 0.97 | -2.02 | 3.43 | 4.77 | 4.76 |
| Borrowings | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Other Liabilities | 0.15 | 0.58 | 0.28 | 0.04 | 0.03 | 0.01 | 0.10 | 0.07 | 0.05 | 0.02 | 0.02 | 0.05 | 0.03 |
| Total Liabilities | 12.24 | 22.87 | 22.95 | 18.00 | 16.23 | 11.73 | 5.65 | 7.88 | 12.50 | 9.48 | 14.93 | 16.30 | 16.27 |
| Fixed Assets | 0.02 | 0.01 | 0.01 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | 10.55 | 17.33 | 22.40 | 17.53 | 14.47 | 11.42 | 5.32 | 7.51 | 11.09 | 8.65 | 12.44 | 12.81 | 12.81 |
| Other Assets | 1.67 | 5.53 | 0.54 | 0.46 | 1.76 | 0.31 | 0.33 | 0.37 | 1.41 | 0.83 | 2.49 | 3.49 | 3.46 |
| Total Assets | 12.24 | 22.87 | 22.95 | 18.00 | 16.23 | 11.73 | 5.65 | 7.88 | 12.50 | 9.48 | 14.93 | 16.30 | 16.27 |
Below is a detailed analysis of the balance sheet data for CNI Research Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.48 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.48 Cr..
- For Reserves, as of Sep 2025, the value is 4.76 Cr.. The value appears to be declining and may need further review. It has decreased from 4.77 Cr. (Mar 2025) to 4.76 Cr., marking a decrease of 0.01 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.03 Cr.. The value appears to be improving (decreasing). It has decreased from 0.05 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.02 Cr..
- For Total Liabilities, as of Sep 2025, the value is 16.27 Cr.. The value appears to be improving (decreasing). It has decreased from 16.30 Cr. (Mar 2025) to 16.27 Cr., marking a decrease of 0.03 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 12.81 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.81 Cr..
- For Other Assets, as of Sep 2025, the value is 3.46 Cr.. The value appears to be declining and may need further review. It has decreased from 3.49 Cr. (Mar 2025) to 3.46 Cr., marking a decrease of 0.03 Cr..
- For Total Assets, as of Sep 2025, the value is 16.27 Cr.. The value appears to be declining and may need further review. It has decreased from 16.30 Cr. (Mar 2025) to 16.27 Cr., marking a decrease of 0.03 Cr..
Notably, the Reserves (4.76 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.30 | -1.27 | 0.28 | -0.38 | -0.11 | -0.50 | -0.25 | -3.61 | 1.72 | -0.86 | 0.85 | -3.94 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1.26 | 13.85 | 0.23 | 6.08 | 128.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 1.26 | 13.85 | 0.23 | 6.08 | 128.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | 190.71 | 8.54 | 0.08 | -2.03 | 126.09 | -0.91 | -15.67 | -11.06 | -1.86 | -0.38 | -0.34 | 268.00 |
| ROCE % | -0.83% | 1.11% | 1.96% | -0.54% | -0.64% | -3.58% | -2.90% | -54.04% | 16.98% | -7.85% | 6.98% | -25.29% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.07 | -0.07 | 0.15 | -0.31 | -0.02 |
| Diluted EPS (Rs.) | 0.07 | -0.07 | 0.15 | -0.31 | -0.02 |
| Cash EPS (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.30 | 0.82 | 1.08 | 0.68 | 0.48 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.30 | 0.82 | 1.08 | 0.68 | 0.48 |
| Revenue From Operations / Share (Rs.) | 0.91 | 0.80 | 0.55 | 0.10 | 0.21 |
| PBDIT / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| PBIT / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| PBT / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| Net Profit / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| PBDIT Margin (%) | 8.12 | -9.26 | 26.98 | -304.76 | -9.97 |
| PBIT Margin (%) | 8.12 | -9.26 | 26.98 | -304.76 | -10.01 |
| PBT Margin (%) | 8.12 | -9.26 | 26.98 | -304.76 | -10.01 |
| Net Profit Margin (%) | 7.98 | -9.26 | 26.68 | -304.82 | -9.94 |
| Return on Networth / Equity (%) | 5.59 | -9.05 | 13.66 | -46.21 | -4.44 |
| Return on Capital Employeed (%) | 5.69 | -9.05 | 13.81 | -46.20 | -4.47 |
| Return On Assets (%) | 5.59 | -9.04 | 13.61 | -45.81 | -4.36 |
| Asset Turnover Ratio (%) | 0.85 | 0.84 | 0.62 | 0.17 | 0.28 |
| Current Ratio (X) | 108.57 | 47.93 | 30.97 | 5.13 | 3.13 |
| Quick Ratio (X) | 108.57 | 47.93 | 30.97 | 5.13 | 3.13 |
| Enterprise Value (Cr.) | 42.86 | 19.74 | 23.39 | 19.28 | 19.90 |
| EV / Net Operating Revenue (X) | 4.10 | 2.13 | 3.67 | 16.29 | 8.03 |
| EV / EBITDA (X) | 50.43 | -23.04 | 13.60 | -5.35 | -80.47 |
| MarketCap / Net Operating Revenue (X) | 4.34 | 2.22 | 3.89 | 16.58 | 8.15 |
| Price / BV (X) | 3.04 | 2.17 | 1.99 | 2.51 | 3.64 |
| Price / Net Operating Revenue (X) | 4.34 | 2.22 | 3.89 | 16.59 | 8.15 |
| EarningsYield | 0.01 | -0.04 | 0.06 | -0.18 | -0.01 |
After reviewing the key financial ratios for CNI Research Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Diluted EPS (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Cash EPS (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 3. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.30. It has increased from 0.82 (Mar 23) to 1.30, marking an increase of 0.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.30. It has increased from 0.82 (Mar 23) to 1.30, marking an increase of 0.48.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 0.91. It has increased from 0.80 (Mar 23) to 0.91, marking an increase of 0.11.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 2. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For PBIT / Share (Rs.), as of Mar 24, the value is 0.07. This value is within the healthy range. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For PBT / Share (Rs.), as of Mar 24, the value is 0.07. This value is within the healthy range. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 2. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For PBDIT Margin (%), as of Mar 24, the value is 8.12. This value is below the healthy minimum of 10. It has increased from -9.26 (Mar 23) to 8.12, marking an increase of 17.38.
- For PBIT Margin (%), as of Mar 24, the value is 8.12. This value is below the healthy minimum of 10. It has increased from -9.26 (Mar 23) to 8.12, marking an increase of 17.38.
- For PBT Margin (%), as of Mar 24, the value is 8.12. This value is below the healthy minimum of 10. It has increased from -9.26 (Mar 23) to 8.12, marking an increase of 17.38.
- For Net Profit Margin (%), as of Mar 24, the value is 7.98. This value is within the healthy range. It has increased from -9.26 (Mar 23) to 7.98, marking an increase of 17.24.
- For Return on Networth / Equity (%), as of Mar 24, the value is 5.59. This value is below the healthy minimum of 15. It has increased from -9.05 (Mar 23) to 5.59, marking an increase of 14.64.
- For Return on Capital Employeed (%), as of Mar 24, the value is 5.69. This value is below the healthy minimum of 10. It has increased from -9.05 (Mar 23) to 5.69, marking an increase of 14.74.
- For Return On Assets (%), as of Mar 24, the value is 5.59. This value is within the healthy range. It has increased from -9.04 (Mar 23) to 5.59, marking an increase of 14.63.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.85. It has increased from 0.84 (Mar 23) to 0.85, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 24, the value is 108.57. This value exceeds the healthy maximum of 3. It has increased from 47.93 (Mar 23) to 108.57, marking an increase of 60.64.
- For Quick Ratio (X), as of Mar 24, the value is 108.57. This value exceeds the healthy maximum of 2. It has increased from 47.93 (Mar 23) to 108.57, marking an increase of 60.64.
- For Enterprise Value (Cr.), as of Mar 24, the value is 42.86. It has increased from 19.74 (Mar 23) to 42.86, marking an increase of 23.12.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.10. This value exceeds the healthy maximum of 3. It has increased from 2.13 (Mar 23) to 4.10, marking an increase of 1.97.
- For EV / EBITDA (X), as of Mar 24, the value is 50.43. This value exceeds the healthy maximum of 15. It has increased from -23.04 (Mar 23) to 50.43, marking an increase of 73.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.34. This value exceeds the healthy maximum of 3. It has increased from 2.22 (Mar 23) to 4.34, marking an increase of 2.12.
- For Price / BV (X), as of Mar 24, the value is 3.04. This value exceeds the healthy maximum of 3. It has increased from 2.17 (Mar 23) to 3.04, marking an increase of 0.87.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.34. This value exceeds the healthy maximum of 3. It has increased from 2.22 (Mar 23) to 4.34, marking an increase of 2.12.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 23) to 0.01, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CNI Research Ltd:
- Net Profit Margin: 7.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.69% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.59% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 108.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 76.84)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.98%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | A/120, Gokul Arcade, Sahar Road, Mumbai Maharashtra 400057 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kishor P Ostwal | Managing Director |
| Mrs. Sangita Ostwal | Non Exe.Non Ind.Director |
| Mr. Mayur Shantilal Doshi | Ind. Non-Executive Director |
| Mr. Arun Kumar S Jain | Ind. Non-Executive Director |
| Mr. Ramkripal Prashant Verma | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of CNI Research Ltd?
CNI Research Ltd's intrinsic value (as of 08 January 2026) is ₹4.37 which is 53.90% lower the current market price of ₹9.48, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹109 Cr. market cap, FY2025-2026 high/low of ₹15.0/7.03, reserves of ₹4.76 Cr, and liabilities of ₹16.27 Cr.
What is the Market Cap of CNI Research Ltd?
The Market Cap of CNI Research Ltd is 109 Cr..
What is the current Stock Price of CNI Research Ltd as on 08 January 2026?
The current stock price of CNI Research Ltd as on 08 January 2026 is ₹9.48.
What is the High / Low of CNI Research Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CNI Research Ltd stocks is ₹15.0/7.03.
What is the Stock P/E of CNI Research Ltd?
The Stock P/E of CNI Research Ltd is .
What is the Book Value of CNI Research Ltd?
The Book Value of CNI Research Ltd is 1.41.
What is the Dividend Yield of CNI Research Ltd?
The Dividend Yield of CNI Research Ltd is 0.00 %.
What is the ROCE of CNI Research Ltd?
The ROCE of CNI Research Ltd is 25.3 %.
What is the ROE of CNI Research Ltd?
The ROE of CNI Research Ltd is 25.3 %.
What is the Face Value of CNI Research Ltd?
The Face Value of CNI Research Ltd is 1.00.